Home › Idiopathic Pulmonary Fibrosis › Connecticut
Idiopathic Pulmonary Fibrosis clinical trials in Connecticut
4 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Connecticut.
Cities in Connecticut
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Yale University, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Yale University School of Medicine, New Haven
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- UConn Health, Farmington
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Yale University, New Haven
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.